BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12730327)

  • 1. Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor.
    Morrison AJ; Herrera RE; Heinsohn EC; Schiff R; Osborne CK
    Mol Endocrinol; 2003 Aug; 17(8):1543-54. PubMed ID: 12730327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.
    Jiang S; Meyer R; Kang K; Osborne CK; Wong J; Oesterreich S
    Mol Endocrinol; 2006 Feb; 20(2):311-20. PubMed ID: 16195251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
    Keeton EK; Brown M
    Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes.
    Söderström M; Vo A; Heinzel T; Lavinsky RM; Yang WM; Seto E; Peterson DA; Rosenfeld MG; Glass CK
    Mol Endocrinol; 1997 Jun; 11(6):682-92. PubMed ID: 9171232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
    Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells.
    Fujita T; Kobayashi Y; Wada O; Tateishi Y; Kitada L; Yamamoto Y; Takashima H; Murayama A; Yano T; Baba T; Kato S; Kawabe Y; Yanagisawa J
    J Biol Chem; 2003 Jul; 278(29):26704-14. PubMed ID: 12738788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells.
    Carroll JS; Lynch DK; Swarbrick A; Renoir JM; Sarcevic B; Daly RJ; Musgrove EA; Sutherland RL
    Cancer Res; 2003 Aug; 63(15):4322-6. PubMed ID: 12907598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
    Li H; Leo C; Schroen DJ; Chen JD
    Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thoughts on tamoxifen resistant breast cancer. Are coregulators the answer or just a red herring?
    Graham JD; Bain DL; Richer JK; Jackson TA; Tung L; Horwitz KB
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):255-9. PubMed ID: 11162933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells.
    Rousseau C; Pettersson F; Couture MC; Paquin A; Galipeau J; Mader S; Miller WH
    J Steroid Biochem Mol Biol; 2003 Jul; 86(1):1-14. PubMed ID: 12943740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.
    Sharma D; Saxena NK; Davidson NE; Vertino PM
    Cancer Res; 2006 Jun; 66(12):6370-8. PubMed ID: 16778215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes.
    Frasor J; Danes JM; Funk CC; Katzenellenbogen BS
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13153-7. PubMed ID: 16141343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.
    Lavinsky RM; Jepsen K; Heinzel T; Torchia J; Mullen TM; Schiff R; Del-Rio AL; Ricote M; Ngo S; Gemsch J; Hilsenbeck SG; Osborne CK; Glass CK; Rosenfeld MG; Rose DW
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):2920-5. PubMed ID: 9501191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
    Zhang X; Jeyakumar M; Petukhov S; Bagchi MK
    Mol Endocrinol; 1998 Apr; 12(4):513-24. PubMed ID: 9544987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors.
    Ince BA; Schodin DJ; Shapiro DJ; Katzenellenbogen BS
    Endocrinology; 1995 Aug; 136(8):3194-9. PubMed ID: 7628351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD.
    Bailey P; Downes M; Lau P; Harris J; Chen SL; Hamamori Y; Sartorelli V; Muscat GE
    Mol Endocrinol; 1999 Jul; 13(7):1155-68. PubMed ID: 10406466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
    Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
    Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
    Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists.
    Huang HJ; Norris JD; McDonnell DP
    Mol Endocrinol; 2002 Aug; 16(8):1778-92. PubMed ID: 12145334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.